Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Nivolumab 25 pembrolizumab 24 Specimen Handling 17 Ipilimumab 16 Magnetic Resonance Spectroscopy 12 Opdualag 7 CTLA-4 Antigen 7 Biopsy 6 trametinib 5 relatlimab 5 dabrafenib 4 binimetinib 4 Paclitaxel 4 Cyclophosphamide 4 fludarabine 3 capivasertib 3 atezolizumab 3 aldesleukin 3 Taxes 3 Standard of Care 3 Pemetrexed 3 Introns 3 Interferon alpha-2 3 Gemcitabine 3 Carboplatin 3 Blood Specimen Collection 3 ulixertinib 2 tislelizumab 2 sargramostim 2 omipalisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × secukinumab × 30 days × Clear all

NCT07237594 2026-06-04

REPLAY

Duke University

Phase 1 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡